Ginkgo Bioworks Inc.
DNA | NYSE
$7.98
+$0.10 (+1.27%)
At close: Sep 21, 2026, 4:00 PM ET
$7.90
-$0.08 (-1.00%)
Pre-market:
Sep 22, 2026, 5:48 AM ET
Market Data
Market Cap $514.76M
Enterprise Value $623.24M
Beta 1.77
Average Volume 1.22M
Shares Outstanding (Diluted) 62.09M
Shares Change YoY 13.19%
Institutional Ownership 54.29%
Exchange NYSE
ISIN US37611X2099
Price Performance
Price Change 1M 9.6%
Price Change 3M -9.9%
Price Change 6M 8.4%
Price Change YTD -8.3%
Price Change 1Y -33.7%
Price Change 3Y -88.7%
Price Change 5Y -98.4%
1M CAGR (ann.) -7.3%
1Y CAGR (ann.) -28.8%
5Y CAGR (ann.) -54.2%
All-Time CAGR -51.7%
Valuation
PE Ratio -1.59
Forward PE N/A
PEG Ratio -0.10
Forward PEG 0.08
PS Ratio 4.66
Forward PS 5.40
PB Ratio 1.24
P/FCF Ratio -2.72
P/Adj. FCF Ratio -2.05
P/OCF Ratio -2.91
EV/Sales 5.57
EV/EBIT -2.11
EV/EBITDA -2.98
EV/FCF -3.25
Earnings Yield -62.9%
FCF Yield -36.8%
Adj. FCF Yield -48.8%
Financial Health
Net Cash $302.16M
Total Debt $404.11M
Cash & Short-Term Investments $302.16M
Total Assets $990.05M
Current Ratio 4.57
Quick Ratio 4.57
Debt / Equity Ratio 0.96
Debt / EBITDA -1.93
Debt / FCF -2.11
OCF / Debt -0.43
Interest Coverage 0.00
Altman Z-Score -8.89
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 80.1%
Operating Profit Margin -259.9%
EBITDA Margin -187.0%
Net Profit Margin -260.0%
FCF Margin -171.6%
Adj. FCF Margin -227.3%
SBC / Revenue 55.7%
SBC Impact (per share) -32.5%
Returns
Return on Assets -29.4%
Return on Equity -60.2%
Return on Invested Capital -31.6%
Return on Capital Employed -31.7%
Return on Tangible Assets -30.8%
Historical Growth (CAGR)
Revenue CAGR 3Y -30.0%
Revenue CAGR 5Y -3.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 67.5%
EPS CAGR 5Y 62.1%
EPS CAGR 10Y N/A
FCF CAGR 3Y 28.5%
FCF CAGR 5Y 11.3%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 11
EPS Growth Next 3Y 18.5%
Revenue Growth Next 3Y 48.9%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.58
EPS Growth Est (next Q) -60.0%
Revenue Est (next Q) $21.57M
Revenue Growth Est (next Q) -44.5%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $5
Price Target Upside -37.3%
Cash Flow
Operating Cash Flow $-172.08M
Free Cash Flow $-191.95M
Adj. Free Cash Flow $-254.27M
FCF Per Share -$3.06
OCF Per Share -$2.74
OCF/S Ratio -152.2%
Income Statement
Revenue $111.86M
Gross Profit $89.6M
Operating Income $-290.69M
EBITDA $-209.15M
Net Income $-290.8M
EPS (Diluted) -$5.02
Revenue / Employee $230.65K
Profit / Employee $-599.59K
Employees 485
Add to Watchlist
Select watchlists to add or remove DNA